AVITA Medical, Inc. (ASX:AVH)
Australia
· Delayed Price · Currency is AUD 2.310
+0.010 (0.43%)
May 13, 2025, 4:10 PM AEST
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 |
| Commercial | 64.02M |
Log In |
Log In |
Log In |
Log In |
| Commercial Growth | 28.62% |
Log In |
Log In |
Log In |
Log In |
| Biomedical Advanced Research and Development Authority Revenue for Right of First Access | 195.00K |
Log In |
Log In |
Log In |
Log In |
| Biomedical Advanced Research and Development Authority Revenue for Right of First Access Growth | -41.79% |
Log In |
Log In |
Log In |
Log In |
| Deferred Commercial | 33.00K |
Log In |
Log In |
Log In |
Log In |
| Deferred Commercial Growth | 0% |
Log In |
Log In |
Log In |
Log In |
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 |
| United States | 62.16M |
Log In |
Log In |
Log In |
Log In |
| United States Growth | 34.08% |
Log In |
Log In |
Log In |
Log In |
| Japan | 1.43M |
Log In |
Log In |
Log In |
Log In |
| Japan Growth | -57.54% |
Log In |
Log In |
Log In |
Log In |
| Australia | 312.00K |
Log In |
Log In |
Log In |
Log In |
| Australia Growth | 40.54% |
Log In |
Log In |
Log In |
Log In |
| United Kingdom | 196.00K |
Log In |
Log In |
Log In |
Log In |
| United Kingdom Growth | 39.01% |
Log In |
Log In |
Log In |
Log In |
| European Union | 155.00K |
Log In |
Log In |
Log In |
Log In |
| European Union Growth | 203.92% |
Log In |
Log In |
Log In |
Log In |